Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Moellering

Showing results (41-50 of 235) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 1998
Antibiotic resistance: lessons for the futureR C Moellering
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 1998
Trovafloxacin: in vitro activity, pharmacokinetics, and clinical experience. IntroductionR C Moellering
Bulletin of the New York Academy of Medicine|November 1, 1982
The third generation cephalosporinsB Farber, R C Moellering
Reviews of Infectious Diseases|July 1, 1983
Therapeutic potential of rifampin in enterococcal infectionsR C Moellering, C Wennersten
Antimicrobial Agents and Chemotherapy|August 1, 1981
Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillinJ I Ward, R C Moellering
Antimicrobial Agents and Chemotherapy|May 1, 1975
Studies of cephalothin: aminoglycoside synergism against enterococciA J Weinstein, R C Moellering
Antimicrobial Agents and Chemotherapy|January 1, 1983
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981B F Farber, R C Moellering
Annals of Internal Medicine|November 1, 1982
Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillinsG M Eliopoulos, R C Moellering
Antimicrobial Agents and Chemotherapy|January 1, 1979
Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococciR H Glew, R C Moellering
Antimicrobial Agents and Chemotherapy|May 1, 1981
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycosideG M Eliopoulos, R C Moellering
Pageof 24

Showing results (41-50 of 235) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 1998
Antibiotic resistance: lessons for the futureR C Moellering
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 1998
Trovafloxacin: in vitro activity, pharmacokinetics, and clinical experience. IntroductionR C Moellering
Bulletin of the New York Academy of Medicine|November 1, 1982
The third generation cephalosporinsB Farber, R C Moellering
Reviews of Infectious Diseases|July 1, 1983
Therapeutic potential of rifampin in enterococcal infectionsR C Moellering, C Wennersten
Antimicrobial Agents and Chemotherapy|August 1, 1981
Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillinJ I Ward, R C Moellering
Antimicrobial Agents and Chemotherapy|May 1, 1975
Studies of cephalothin: aminoglycoside synergism against enterococciA J Weinstein, R C Moellering
Antimicrobial Agents and Chemotherapy|January 1, 1983
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981B F Farber, R C Moellering
Annals of Internal Medicine|November 1, 1982
Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillinsG M Eliopoulos, R C Moellering
Antimicrobial Agents and Chemotherapy|January 1, 1979
Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococciR H Glew, R C Moellering
Antimicrobial Agents and Chemotherapy|May 1, 1981
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycosideG M Eliopoulos, R C Moellering
Pageof 24